Loading provider…
Loading provider…
Nephrology Physician in Marshall, MN
NPI: 1356313522Primary Practice Location
AVERA MARSHALL REGIONAL MEDICAL CTR
300 S Bruce St, Marshall, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get M.D. Fernando's Phone Numberphone_androidMobile
Get M.D. Fernando's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
MN State Medical License
1998 - 2025
AL State Medical License
1996 - 2001

American Board of Internal Medicine
Nephrology
Stanford Health Care-Sponsored Stanford University
Fellowship • Nephrology
1993 - 1997
University of Oxford
Ph.D. • 1991
Until 1991
Federal University of Rio Grande do Sul School of Medicine
Medical School
Until 1982
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Internal Medicine
1997 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 33 | 42 |
| 2 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 20 | 43 |
| 3 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 11 | 13 |
Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
Authors: Musab Hommos, Andrew Rule, Richard Glassock
Journal: J Am Soc Nephrol
Publication Date: 2022-08-03
Lead Sponsor: Mayo Clinic
Collaborators: Stanford University, University of Alabama at Birmingham, University of Michigan, Columbia University, The Cleveland Clinic, Medical College of Wisconsin, Case Western Reserve University, University Health Network, Toronto, University of Washington, Washington University School of Medicine, University of British Columbia, University of Toronto, University of Mississippi Medical Center, Ohio State University, NYU Langone Health, University of Kansas Medical Center, Sunnybrook Health Sciences Centre, University of Manchester, CHU de Quebec-Universite Laval, Florida International University, University of Arizona, Applied Health Research Centre, Fulk Family Foundation
Intervention / Treatment: DRUG: Rituximab, DRUG: Cyclosporine
Lead Sponsor: Mayo Clinic
Intervention / Treatment: DRUG: Aliskiren
Lead Sponsor: Mayo Clinic
Collaborators: Genentech, Inc., Biogen, Stanford University, Columbia University, Ohio State University, University of North Carolina, Chapel Hill
Intervention / Treatment: DRUG: ACE/ARB, DIETARY_SUPPLEMENT: Omega-3 Fatty Acid Fish Oil Supplement, DRUG: Intravenous Rituximab